Concepts (170)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
| Sex Workers | 6 | 2018 | 348 | 1.47 | Why? |
| Methamphetamine | 3 | 2018 | 82 | 1.43 | Why? |
| Substance Abuse, Intravenous | 8 | 2019 | 411 | 1.38 | Why? |
| Iran | 29 | 2021 | 5467 | 1.11 | Why? |
| Safe Sex | 3 | 2017 | 135 | 0.98 | Why? |
| Amphetamine-Related Disorders | 2 | 2018 | 31 | 0.86 | Why? |
| Condoms | 2 | 2017 | 235 | 0.77 | Why? |
| Herbal Medicine | 1 | 2019 | 69 | 0.75 | Why? |
| Sexual Behavior | 5 | 2018 | 1322 | 0.65 | Why? |
| Air Travel | 1 | 2020 | 585 | 0.50 | Why? |
| Needle-Exchange Programs | 3 | 2019 | 146 | 0.49 | Why? |
| Sexually Transmitted Diseases | 2 | 2018 | 694 | 0.48 | Why? |
| Phytotherapy | 1 | 2019 | 743 | 0.46 | Why? |
| Health Knowledge, Attitudes, Practice | 4 | 2018 | 8811 | 0.44 | Why? |
| Leishmania tropica | 3 | 2019 | 10 | 0.44 | Why? |
| Risk-Taking | 4 | 2019 | 508 | 0.42 | Why? |
| Unsafe Sex | 4 | 2019 | 139 | 0.42 | Why? |
| Leishmaniasis, Cutaneous | 3 | 2019 | 48 | 0.40 | Why? |
| HIV Infections | 10 | 2021 | 11620 | 0.38 | Why? |
| Sexual Partners | 3 | 2018 | 612 | 0.36 | Why? |
| Substance-Related Disorders | 2 | 2018 | 2038 | 0.31 | Why? |
| Harm Reduction | 3 | 2019 | 392 | 0.30 | Why? |
| Drug Users | 2 | 2017 | 234 | 0.27 | Why? |
| Mass Screening | 3 | 2020 | 8005 | 0.26 | Why? |
| Population Surveillance | 2 | 2019 | 4967 | 0.22 | Why? |
| Coronavirus | 2 | 2020 | 18339 | 0.21 | Why? |
| Prevalence | 13 | 2021 | 25773 | 0.21 | Why? |
| Marital Status | 2 | 2018 | 186 | 0.21 | Why? |
| Goat Diseases | 1 | 2019 | 36 | 0.19 | Why? |
| Arginase | 1 | 2018 | 64 | 0.19 | Why? |
| Organizational Objectives | 1 | 2021 | 180 | 0.19 | Why? |
| Sheep Diseases | 1 | 2019 | 55 | 0.19 | Why? |
| Needle Sharing | 1 | 2018 | 23 | 0.19 | Why? |
| Nitric Oxide Synthase Type II | 1 | 2018 | 119 | 0.19 | Why? |
| Antiprotozoal Agents | 1 | 2019 | 83 | 0.18 | Why? |
| Coxiella burnetii | 1 | 2019 | 120 | 0.18 | Why? |
| Methanol | 1 | 2020 | 149 | 0.18 | Why? |
| Milk | 1 | 2019 | 158 | 0.17 | Why? |
| Sex Work | 1 | 2018 | 96 | 0.17 | Why? |
| Confidence Intervals | 1 | 2020 | 744 | 0.17 | Why? |
| Preventive Medicine | 1 | 2021 | 242 | 0.17 | Why? |
| Interrupted Time Series Analysis | 1 | 2020 | 868 | 0.16 | Why? |
| Central Nervous System Stimulants | 1 | 2017 | 111 | 0.16 | Why? |
| Vagina | 1 | 2019 | 327 | 0.16 | Why? |
| Adult | 25 | 2021 | 244371 | 0.16 | Why? |
| Young Adult | 16 | 2020 | 93724 | 0.15 | Why? |
| Toll-Like Receptors | 1 | 2018 | 365 | 0.15 | Why? |
| Drug Synergism | 1 | 2019 | 833 | 0.15 | Why? |
| Cross-Sectional Studies | 13 | 2021 | 53120 | 0.14 | Why? |
| Women | 1 | 2017 | 159 | 0.14 | Why? |
| Surveys and Questionnaires | 8 | 2018 | 43792 | 0.14 | Why? |
| Family Planning Services | 1 | 2017 | 236 | 0.13 | Why? |
| Selenium | 1 | 2019 | 412 | 0.13 | Why? |
| Xylazine | 1 | 2012 | 1 | 0.13 | Why? |
| Infectious Disease Incubation Period | 1 | 2020 | 1033 | 0.12 | Why? |
| Female | 23 | 2021 | 380317 | 0.12 | Why? |
| Alcohol Drinking | 3 | 2020 | 1663 | 0.12 | Why? |
| Population Density | 1 | 2017 | 694 | 0.11 | Why? |
| Humans | 34 | 2021 | 930598 | 0.11 | Why? |
| Social Networking | 1 | 2018 | 737 | 0.11 | Why? |
| Male | 21 | 2021 | 367725 | 0.10 | Why? |
| Neoplasms | 1 | 2019 | 17251 | 0.10 | Why? |
| Adolescent | 8 | 2018 | 86841 | 0.10 | Why? |
| Students | 2 | 2018 | 5255 | 0.10 | Why? |
| Self Report | 2 | 2018 | 3802 | 0.09 | Why? |
| Drug Delivery Systems | 1 | 2019 | 1365 | 0.09 | Why? |
| Multilevel Analysis | 2 | 2019 | 104 | 0.09 | Why? |
| Pneumonia, Viral | 4 | 2020 | 243684 | 0.09 | Why? |
| Coronavirus Infections | 4 | 2020 | 253789 | 0.09 | Why? |
| Risk Factors | 7 | 2021 | 71621 | 0.09 | Why? |
| Tumor Necrosis Factor-alpha | 1 | 2018 | 2483 | 0.09 | Why? |
| Syringes | 2 | 2019 | 70 | 0.09 | Why? |
| Anti-HIV Agents | 1 | 2021 | 2209 | 0.09 | Why? |
| Research | 1 | 2020 | 2115 | 0.09 | Why? |
| Internationality | 1 | 2020 | 3297 | 0.09 | Why? |
| Leadership | 1 | 2021 | 2241 | 0.08 | Why? |
| Polymerase Chain Reaction | 2 | 2019 | 6740 | 0.08 | Why? |
| Pandemics | 9 | 2021 | 389249 | 0.08 | Why? |
| Evidence-Based Medicine | 1 | 2020 | 3228 | 0.08 | Why? |
| Blood Cell Count | 1 | 2012 | 1101 | 0.08 | Why? |
| Hemoglobins | 1 | 2012 | 958 | 0.08 | Why? |
| Oxygen Inhalation Therapy | 1 | 2020 | 3629 | 0.08 | Why? |
| Monocytes | 1 | 2018 | 2978 | 0.08 | Why? |
| Health Education | 1 | 2017 | 1539 | 0.08 | Why? |
| Socioeconomic Factors | 3 | 2018 | 8495 | 0.07 | Why? |
| Logistic Models | 2 | 2017 | 9089 | 0.07 | Why? |
| Odds Ratio | 1 | 2017 | 5861 | 0.07 | Why? |
| Universities | 2 | 2018 | 4374 | 0.07 | Why? |
| Middle Aged | 12 | 2021 | 270681 | 0.07 | Why? |
| Camelus | 1 | 2012 | 1425 | 0.06 | Why? |
| Cities | 3 | 2020 | 4937 | 0.06 | Why? |
| Models, Theoretical | 1 | 2020 | 6659 | 0.06 | Why? |
| Information Dissemination | 1 | 2017 | 2986 | 0.06 | Why? |
| Coinfection | 1 | 2021 | 6820 | 0.05 | Why? |
| Acute Kidney Injury | 1 | 2021 | 5762 | 0.05 | Why? |
| Epidemics | 1 | 2021 | 6407 | 0.05 | Why? |
| Tetrazolium Salts | 1 | 2019 | 9 | 0.05 | Why? |
| Parasitic Sensitivity Tests | 1 | 2019 | 10 | 0.05 | Why? |
| Formazans | 1 | 2019 | 5 | 0.05 | Why? |
| Toll-Like Receptor 10 | 1 | 2018 | 10 | 0.05 | Why? |
| Internet | 1 | 2017 | 6204 | 0.05 | Why? |
| Trichomonas Infections | 1 | 2018 | 24 | 0.05 | Why? |
| Goats | 1 | 2019 | 217 | 0.05 | Why? |
| Condylomata Acuminata | 1 | 2018 | 62 | 0.05 | Why? |
| Host-Parasite Interactions | 1 | 2018 | 112 | 0.04 | Why? |
| DNA, Protozoan | 1 | 2018 | 77 | 0.04 | Why? |
| Sheep | 1 | 2019 | 420 | 0.04 | Why? |
| Toll-Like Receptor 2 | 1 | 2018 | 198 | 0.04 | Why? |
| Public Health | 2 | 2020 | 16359 | 0.04 | Why? |
| Marriage | 1 | 2017 | 83 | 0.04 | Why? |
| Time Factors | 1 | 2020 | 31397 | 0.04 | Why? |
| Culture | 1 | 2020 | 370 | 0.04 | Why? |
| Age Factors | 1 | 2017 | 21039 | 0.04 | Why? |
| Chlamydia Infections | 1 | 2018 | 248 | 0.04 | Why? |
| Toll-Like Receptor 4 | 1 | 2018 | 390 | 0.04 | Why? |
| HIV Seropositivity | 1 | 2017 | 320 | 0.04 | Why? |
| Models, Organizational | 1 | 2021 | 908 | 0.04 | Why? |
| Aged, 80 and over | 3 | 2021 | 88759 | 0.04 | Why? |
| Respiration, Artificial | 1 | 2020 | 22116 | 0.03 | Why? |
| Gonorrhea | 1 | 2018 | 315 | 0.03 | Why? |
| Peer Group | 1 | 2018 | 402 | 0.03 | Why? |
| Papillomaviridae | 1 | 2018 | 404 | 0.03 | Why? |
| Syphilis | 1 | 2018 | 318 | 0.03 | Why? |
| Intensive Care Units | 1 | 2020 | 29594 | 0.03 | Why? |
| Cell Survival | 1 | 2019 | 1581 | 0.03 | Why? |
| Quarantine | 1 | 2020 | 18418 | 0.03 | Why? |
| Injections, Spinal | 1 | 2012 | 61 | 0.03 | Why? |
| Down-Regulation | 1 | 2018 | 1416 | 0.03 | Why? |
| Social Class | 1 | 2020 | 1360 | 0.03 | Why? |
| Health Personnel | 1 | 2021 | 29646 | 0.03 | Why? |
| Up-Regulation | 1 | 2018 | 2249 | 0.03 | Why? |
| Aged | 4 | 2021 | 215776 | 0.03 | Why? |
| Interpersonal Relations | 1 | 2018 | 926 | 0.03 | Why? |
| Injections, Intramuscular | 1 | 2012 | 800 | 0.02 | Why? |
| Papillomavirus Infections | 1 | 2018 | 861 | 0.02 | Why? |
| Uncertainty | 1 | 2020 | 1888 | 0.02 | Why? |
| Bayes Theorem | 1 | 2019 | 3237 | 0.02 | Why? |
| Program Evaluation | 1 | 2017 | 1929 | 0.02 | Why? |
| Case-Control Studies | 2 | 2018 | 17671 | 0.02 | Why? |
| Sensitivity and Specificity | 2 | 2020 | 22971 | 0.02 | Why? |
| Disaster Planning | 1 | 2021 | 1680 | 0.02 | Why? |
| Gene Expression | 1 | 2018 | 3332 | 0.02 | Why? |
| Health Surveys | 1 | 2019 | 2841 | 0.02 | Why? |
| Betacoronavirus | 3 | 2020 | 204454 | 0.02 | Why? |
| Perception | 1 | 2019 | 2827 | 0.02 | Why? |
| Gene Expression Profiling | 1 | 2019 | 3788 | 0.02 | Why? |
| Macrophages | 1 | 2019 | 2784 | 0.02 | Why? |
| Consensus | 1 | 2021 | 6345 | 0.02 | Why? |
| Multivariate Analysis | 1 | 2017 | 5440 | 0.02 | Why? |
| Enzyme-Linked Immunosorbent Assay | 1 | 2020 | 7868 | 0.02 | Why? |
| Seroepidemiologic Studies | 1 | 2020 | 10017 | 0.02 | Why? |
| Smoking | 1 | 2018 | 3358 | 0.02 | Why? |
| Animals | 3 | 2019 | 78931 | 0.02 | Why? |
| Cell Line | 1 | 2019 | 12040 | 0.02 | Why? |
| Immunoglobulin M | 1 | 2020 | 9091 | 0.02 | Why? |
| Predictive Value of Tests | 1 | 2018 | 9537 | 0.02 | Why? |
| Dose-Response Relationship, Drug | 1 | 2012 | 3776 | 0.02 | Why? |
| Developing Countries | 1 | 2018 | 4283 | 0.01 | Why? |
| Health Policy | 1 | 2020 | 6242 | 0.01 | Why? |
| Health Status Disparities | 1 | 2017 | 4072 | 0.01 | Why? |
| Mice | 1 | 2019 | 21357 | 0.01 | Why? |
| Incidence | 1 | 2021 | 25622 | 0.01 | Why? |
| Global Health | 1 | 2020 | 13911 | 0.01 | Why? |
| Cytokines | 1 | 2019 | 15010 | 0.01 | Why? |
| Immunoglobulin G | 1 | 2020 | 21571 | 0.01 | Why? |
| Child, Preschool | 1 | 2018 | 36283 | 0.01 | Why? |
| Delivery of Health Care | 1 | 2020 | 15909 | 0.01 | Why? |
| Treatment Outcome | 1 | 2020 | 51732 | 0.01 | Why? |
| Child | 1 | 2018 | 70012 | 0.01 | Why? |
| Antibodies, Viral | 1 | 2020 | 51949 | 0.01 | Why? |
Sharifi's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts
(170)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(142)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_